Publications by authors named "Brian Overstreet"

Claim this Profile
A
Analysis of Spontaneous Postmarket Case Reports Submitted to the FDA Regarding Thromboembolic Adverse Events and JAK Inhibitors.
Abril Verden, Mo Dimbil, Robert Kyle, Brian Overstreet, Keith B Hoffman

Drug Saf· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Drug Safety Rating System Based on Postmarketing Costs Associated with Adverse Events and Patient Outcomes.
Keith B Hoffman, Mo Dimbil, Robert F Kyle, Nicholas P Tatonetti, Colin B Erdman, Brian M Overstreet

J Manag Care Spec Pharm· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Weber effect and the United States Food and Drug Administration's Adverse Event Reporting System (FAERS): analysis of sixty-two drugs approved from 2006 to 2010.
Keith B Hoffman, Mo Dimbil, Colin B Erdman, Nicholas P Tatonetti, Brian M Overstreet

Drug Saf· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis